Immunological and regenerative properties of cord blood stem cells

被引:50
作者
Francese, Roberto [3 ,4 ]
Fiorina, Paolo [1 ,2 ,5 ]
机构
[1] Harvard Univ, Sch Med, Childrens Hosp, Div Nephrol,TRC, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Nephrol,TRC, Boston, MA 02115 USA
[3] Univ Turin, Dipartimento Med & Oncol Sperimentale, I-10124 Turin, Italy
[4] Sorgente Res, Milan, Italy
[5] Ist Sci San Raffaele, Dept Med, I-20132 Milan, Italy
关键词
Cord blood stem cells; Immune regulation; Regenerative medicine; Transplantation; EMBRYONIC-LIKE CELLS; VERSUS-HOST-DISEASE; T REGULATORY CELLS; DIABETIC NOD MICE; UMBILICAL-CORD; BONE-MARROW; IN-VITRO; UNRELATED DONORS; ACUTE-LEUKEMIA; TRANSPLANTATION;
D O I
10.1016/j.clim.2010.04.010
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Cord blood stem cells (CB-SCs) have shown impressive immunological and regenerative capabilities. In this review, we intend to review the state-of-the-art knowledge on CB-SCs characteristics and function as well as immunological and regenerative properties. We report an itemized classification of CB-SCs populations, which is important to better understand which tissues can be replaced using CB-SCs and how the generation of induced pluripotent stem cells from CB-SCs is changing the field. Furthermore, we will discuss new findings on the immunosuppressive capability of CB-SCs in autoimmune disease (e.g., type 1 diabetes). Our review will demonstrate how CB-SCs could become a powerful tool not only for regenerative medicine but for autoimmune and inflammatory diseases as well. (C) 2010 Elsevier Inc. All rights reserved.
引用
收藏
页码:309 / 322
页数:14
相关论文
共 84 条
[1]   Immunomodulation by mesenchymal stem cells - A potential therapeutic strategy for type 1 diabetes [J].
Abdi, Reza ;
Fiorina, Paolo ;
Adra, Chaker N. ;
Atkinson, Mark ;
Sayegh, Mohamed H. .
DIABETES, 2008, 57 (07) :1759-1767
[2]   Human mesenchymal stem cells modulate allogeneic immune cell responses [J].
Aggarwal, S ;
Pittenger, MF .
BLOOD, 2005, 105 (04) :1815-1822
[3]   Can stem cells cross lineage boundaries? [J].
Anderson, DJ ;
Gage, FH ;
Weissman, IL .
NATURE MEDICINE, 2001, 7 (04) :393-395
[4]   The programmed death-1 (PD-1) pathway regulates autoimmune diabetes in nonobese diabetic (NOD) mice [J].
Ansari, MJI ;
Salama, AD ;
Chitnis, T ;
Smith, RN ;
Yagita, H ;
Akiba, H ;
Yamazaki, T ;
Azuma, M ;
Iwai, H ;
Khoury, SJ ;
Auchincloss, H ;
Sayegh, MH .
JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 198 (01) :63-69
[5]   Cord blood in vitro expanded CD41+ cells:: identification of novel components of megakaryocytopoiesis [J].
Balduini, A ;
D'Apolito, M ;
Arcelli, D ;
Conti, V ;
Pecci, A ;
Pietra, D ;
Danova, M ;
Benvenuto, F ;
Perotti, C ;
Zelante, L ;
Volinia, S ;
Balduini, CL ;
Savoia, A .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2006, 4 (04) :848-860
[6]   Survival after transplantation of unrelated donor umbilical cord blood is comparable to that of human leukocyte antigen-matched unrelated donor bone marrow: results of a matched-pair analysis [J].
Barker, JN ;
Davies, SM ;
DeFor, T ;
Ramsay, NKC ;
Weisdorf, DJ ;
Wagner, JE .
BLOOD, 2001, 97 (10) :2957-2961
[7]  
Brown MA, 2009, TISSUE ENG PT A, V15, P3575, DOI [10.1089/ten.tea.2008.0444, 10.1089/ten.TEA.2008.0444]
[8]   High-efficiency recovery of functional hematopoietic progenitor and stem cells from human cord blood cryopreserved for 15 years [J].
Broxmeyer, HE ;
Srour, EF ;
Hangoc, G ;
Cooper, S ;
Anderson, SA ;
Bodine, DM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (02) :645-650
[9]   Future of cord blood for oncology uses [J].
Brunstein, C. G. ;
Weisdorf, D. J. .
BONE MARROW TRANSPLANTATION, 2009, 44 (10) :699-707
[10]   IL-21 blockade reduces graft-versus-host disease mortality by supporting inducible T regulatory cell generation [J].
Bucher, Christoph ;
Koch, Lisa ;
Vogtenhuber, Christine ;
Goren, Emily ;
Munger, Meghan ;
Panoskaltsis-Mortari, Angela ;
Sivakumar, Pallavur ;
Blazar, Bruce R. .
BLOOD, 2009, 114 (26) :5375-5384